Uncomplicated Severe Acute MalnutritionSAMPOORNANCT01705769
Effects of Three Feeding Regimens on Recovery of Uncomplicated Severely Acute Malnourished Children
A study testing Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced and High energy and micronutrient rich foods in people with Uncomplicated Severe Acute Malnutrition, run by Society for Applied Studies at 3 sites in India.
Trial summary
This project aims to assess the efficacy of three options under consideration in India for home management of Severe Acute Malnutrition (SAM). The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or… Read more about this study
- Who is it for?
- Ages 6 to 59 months
- Conditions the study is for
- Uncomplicated Severe Acute Malnutrition
- What is being tested?
- Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced and High energy and micronutrient rich foods
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 911 participants
- Where
- 3 sitesIndia
- Study dates
- Oct 2012to Apr 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 59 months
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Age 6 to 59 months
- SAM, defined as Weight for height less than -3 SD of WHO standard or oedema of both feet or both.
Who cannot join
- Complicated SAM defined as child with SAM having signs of severe illness requiring hospitalization
- Known allergy to animal milk or peanuts
- Likely to leave the study area permanently in the next 16 weeks
Trial locations and contacts
3 sites in 1 country.
India3 sites
Centre for Health Research and Development, Society for Applied Studies
New Delhi, National Capital Territory of Delhi, 110062
Action Research & Training for Health (ARTH)
Udaipur, Rajasthan, 313004
Christian Medical College
Vellore, Tamil Nadu, 632002
About this study
Official title: To Evaluate the Impact of Three Feeding Regimens on the Recovery of Children From Uncomplicated Severe Acute Malnutrition (SAM) in India and to Use the Evidence to Inform National Policy
This project aims to assess the efficacy of three options under consideration in India for home management of Severe Acute Malnutrition (SAM). The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or locally produced Ready to Use Therapeutic Foods (RUTF) for recovery from uncomplicated SAM after 16 weeks of management, compared with an augmented home-prepared foods regimen. The trial will enroll 911 children with uncomplicated SAM and will have enough statistical power to detect a 15% or greater difference in recovery rates between either one of the intervention groups compared with comparison group.
Read the detailed description
India accounts for over half the global burden of severe acute malnutrition (SAM) in the world. While it is important to accelerate efforts to prevent SAM, effective management of children suffering from it is critical for reducing child mortality and achieving MDG1 and MDG4.
Available evidence mostly from studies in Africa suggest that home based management of uncomplicated SAM with Ready to Use Therapeutic Foods (RUTF) is at least as efficacious as facility-based management and that locally produced RUTF is as efficacious as centrally produced RUTF. More evidence on efficacy and effectiveness of home based management using RUTF is needed to decide if this intervention offers substantial advantages over home-prepared foods in the Indian settings. Additionally, there is a demand to generate evidence of efficacy of locally produced RUTF as compared to that of centrally produced RUTF. These issues can only be resolved through a well designed randomized controlled trial.
This project therefore aims to assess the efficacy of three options under consideration in India for home management of SAM. The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or locally produced Ready to Use Therapeutic Foods (RUTF) for recovery from uncomplicated SAM after 16 weeks of management, compared with an augmented home-prepared foods regimen. The trial will enroll 911 children with uncomplicated SAM and will have enough statistical power to detect a 15% or greater difference in recovery rates between either one of the intervention groups compared with the comparison group.
Participants: The study will be conducted in three sites - urban slums and resettlement colonies in the national capital region, rural (predominantly tribal) Rajasthan, rural and urban Tamil Nadu. Field workers will survey the study area to measure mid-upper arm circumference (MUAC) in children 6 to 59 months of age and refer children with MUAC less than 13 cm to a study clinic. At the study clinic, anthropometric measurements will be taken and children with weight for height less than -3 SD of the WHO standards or oedema of both feet will be offered participation in the study.
Intervention and Comparison Regimes for Home Management of SAM
- Children randomized to the first intervention arm (Arm 1) will receive a centrally produced RUTF.
- Children randomized to the second intervention arm (Arm 2) will receive a locally produced RUTF.
- Children randomized to the comparison group (Arm 3) will receive augmented Home-Prepared Foods.
The amount of food advised for each child in all the 3 study arms are calculated to provide 175cal/kg body weight per day. These foods will be given to children from the time of enrollment until recovery (but not beyond 16 weeks). Caregivers of all enrolled children will receive counseling on frequency of feeding, amounts to be fed, encouraging children to continue breastfeeding and good hygiene practices. Additional support through a volunteer from the community will be provided to mothers who give consent, to assist in feeding the child.
Management Phases: The management will be in two phases:
Treatment Phase: From enrolment until recovery or 16 weeks (whichever is earlier), enrolled children will be provided the foods according to the study group they are randomized to, and counselled on their use.
Sustenance Phase: After completion of the treatment phase, children in all arms will be referred to the closest Anganwadi centre from where he/she will access supplementary foods given to children as a part of the ICDS strategy. The sustenance phase will last for 16 weeks after end of treatment phase.
Outcomes: A trained and standardized team of field workers will conduct weekly anthropometric measurements and also record morbidity, hospitalizations and deaths from enrolment, weekly till recovery or 16 weeks whichever is earlier. In addition, mortality and hospitalization data will be collected at 16 weeks post treatment phase.
The primary outcome will be recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema).
Secondary outcomes will include:
- To compare the weight gain (in grams/kg body weight/day) from enrolment till recovery, or till 16 weeks in those who do not attain recovery, at 16 weeks after recovery.
- To compare the time required to reach recovery (in weeks).
- To determine the incidence and prevalence of diarrhea, ARI and fever during the treatment phase
- To compare the mortality and hospitalizations during the treatment phase, 16 weeks after recovery
- To compare the perceptions of families, health care providers and ICDS functionaries regarding feasibility of use of the feeding regimens in a sub sample from enrolment tom completion of treatment phase
- To ascertain factors which affect recovery, at 16 weeks post enrolment in those who do not recover.
- To compare the perceptions of families regarding Anganwadi centre experience at the end of sustenance phase.
- To compare the proportion of children with weight for height greater than or equal to -2 SD and absence of oedema feet at 16 weeks after recovery (or 32 weeks after enrolment for those who do not recover)
- To document the costs of implementing the feeding regimens till end of treatment phase.
This will include:
- Estimation of costs of human resource and other inputs
- Estimation of household costs
- Costs per week per child estimated based on total costs and covered population
The project has been approved by the National Research Alliance for SAM constituted by the Department of Health and Family Welfare, Department of Health Research and Department of Biotechnology. It will be coordinated by Centre for Health Research and Development-Society for Applied Studies. WHO will provide technical support and monitoring for the study implementation as a response to a request from the Alliance. Oversight to the study will be provided by a Technical Advisory group constituted by the Alliance and a Data Safety Monitoring Board. Clearances have been sought from the state governments of Delhi, Rajasthan and Tamil Nadu.
- Conditions
- Uncomplicated Severe Acute Malnutrition
- Being tested
- Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced, High energy and micronutrient rich foods
- Keywords
- treatment, severe acute malnutrition
- Medical subject headings
- Severe Acute Malnutrition
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ready to Use Therapeutic Food-Centrally producedOther
Ready to Use Therapeutic Food-Centrally produced by an Indian company.
Ready to Use Therapeutic Food-Locally producedOther
Ready to Use Therapeutic Food prepared by the study team
High energy and micronutrient rich foodsOther
High energy and micronutrient rich foods prepared by caregivers at home using ingredients provided to them
| Study group | Role | What they receive |
|---|---|---|
| RUTF-Centrally produced | Experimental | Ready to Use Therapeutic Food-Centrally produced by an Indian company Receives: Other: Ready to Use Therapeutic Food-Centrally produced |
| RUTF-Locally produced | Experimental | Ready to Use Therapeutic Food-Locally produced by the study team at each study site Receives: Other: Ready to Use Therapeutic Food-Locally produced |
| High energy and micronutrient rich foods | Active comparator | High energy and micronutrient rich foods prepared by caregivers at home using ingredients provided to them Receives: Other: High energy and micronutrient rich foods |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema of both feet)
Measured: Weekly till recovery or 16 weeks after enrollment, whichever is earlier
Secondary outcomes (9)
Mortality and hospitalizations
Measured: Weekly till 16 weeks or recovery and at end of sustenance phase
Rate of weight gain (grams/kg body wt/day)
Measured: From enrollment till recovery or 16 weeks whichever is earlier
Time required to reach recovery
Measured: From enrollment till recovery or 16 weeks whichever is earlier
Íncidence and prevalence of diarrhea, ARI and fever during treatment phase
Measured: From enrollment till recovery or 16 weeks whichever is earlier
Proportion of children with weight for height greater than or equal to -2 SD and absence of oedema of feet
Measured: At the end of sustenance phase
Cost of three feeding regimens
Measured: Enrollment to end of treatment phase
Feedback from families, health care providers and ICDS functionaries about the feeding regimens regarding perceptions and feasibility of use
Measured: Enrollment to end study
Factors which affect recovery
Measured: At 16 weeks post enrolment in those that have not recovered
Perception of families regarding anganwadi centre experiences at the end of sustenance phase
Measured: from end of treatment phase to end of sustanence phase
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Oct 2012 (estimated)
- Study startOct 2012
- Primary completionApr 2015
- Study completionApr 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Uncomplicated Severe Acute MalnutritionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 911 participants (actual)
Sponsor and investigators
- Lead sponsor
- Society for Applied Studies
- Sponsor type
- University, hospital or other
- Collaborators
- Arth, Christian Medical College, Vellore, India, World Health Organization
- Responsible party
- Principal investigator, NBhandari, Society for Applied Studies
- Investigators
- Nita Bhandari, MD, PhD, Principal investigator, Centre for Health Research and Development, Society for Applied Studies
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01705769
- Sponsor's protocol ID
- RPC538
- Other IDs
- CTRI/2012/10/003054
- Acronym
- SAMPOORNA
- Status last verified
- Jun 2015
- First submitted
- 8 Oct 2012
- Last updated
- 8 Jun 2015
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Garg CC, Mazumder S, Taneja S, Shekhar M, Mohan SB, Bose A, Iyengar SD, Bahl R, Martines J, Bhandari N. Costing of three feeding regimens for home-based management of children with uncomplicated severe acute malnutrition from a randomised trial in India. BMJ Glob Health. 2018 Mar 6;3(2):e000702. doi: 10.1136/bmjgh-2017-000702. eCollection 2018.
PubMed 29527358Bhandari N, Mohan SB, Bose A, Iyengar SD, Taneja S, Mazumder S, Pricilla RA, Iyengar K, Sachdev HS, Mohan VR, Suhalka V, Yoshida S, Martines J, Bahl R. Efficacy of three feeding regimens for home-based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Glob Health. 2016 Dec 30;1(4):e000144. doi: 10.1136/bmjgh-2016-000144. eCollection 2016.
PubMed 28588982
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- To Evaluate the Impact of Three Feeding Regimens on the Recovery of Children From Uncomplicated Severe Acute Malnutrition (SAM) in India and to Use the Evidence to Inform National Policy
- ClinicalTrials.gov ID
- NCT01705769
- Acronym / sponsor ID
- SAMPOORNA / RPC538
- Conditions
- Uncomplicated Severe Acute Malnutrition
- Keywords
- treatment, severe acute malnutrition
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 911 participants (actual)
- Lead sponsor
- Society for Applied StudiesUniversity, hospital or other
- Collaborators
- Arth, Christian Medical College, Vellore, India, World Health Organization
- Study start
- Oct 2012
- Primary completion
- Apr 2015 (actual)
- Study completion
- Apr 2015 (actual)
- First posted
- 12 Oct 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project aims to assess the efficacy of three options under consideration in India for home management of Severe Acute Malnutrition (SAM). The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or locally produced Ready to Use Therapeutic Foods (RUTF) for recovery from uncomplicated SAM after 16 weeks of management, compared with an augmented home-prepared foods regimen. The trial will enroll 911 children with uncomplicated SAM and will have enough statistical power to detect a 15% or greater difference in recovery rates between either one of the intervention groups compared with comparison group.
Detailed description
India accounts for over half the global burden of severe acute malnutrition (SAM) in the world. While it is important to accelerate efforts to prevent SAM, effective management of children suffering from it is critical for reducing child mortality and achieving MDG1 and MDG4.
Available evidence mostly from studies in Africa suggest that home based management of uncomplicated SAM with Ready to Use Therapeutic Foods (RUTF) is at least as efficacious as facility-based management and that locally produced RUTF is as efficacious as centrally produced RUTF. More evidence on efficacy and effectiveness of home based management using RUTF is needed to decide if this intervention offers substantial advantages over home-prepared foods in the Indian settings. Additionally, there is a demand to generate evidence of efficacy of locally produced RUTF as compared to that of centrally produced RUTF. These issues can only be resolved through a well designed randomized controlled trial.
This project therefore aims to assess the efficacy of three options under consideration in India for home management of SAM. The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or locally produced Ready to Use Therapeutic Foods (RUTF) for recovery from uncomplicated SAM after 16 weeks of management, compared with an augmented home-prepared foods regimen. The trial will enroll 911 children with uncomplicated SAM and will have enough statistical power to detect a 15% or greater difference in recovery rates between either one of the intervention groups compared with the comparison group.
Participants: The study will be conducted in three sites - urban slums and resettlement colonies in the national capital region, rural (predominantly tribal) Rajasthan, rural and urban Tamil Nadu. Field workers will survey the study area to measure mid-upper arm circumference (MUAC) in children 6 to 59 months of age and refer children with MUAC less than 13 cm to a study clinic. At the study clinic, anthropometric measurements will be taken and children with weight for height less than -3 SD of the WHO standards or oedema of both feet will be offered participation in the study.
Intervention and Comparison Regimes for Home Management of SAM
- Children randomized to the first intervention arm (Arm 1) will receive a centrally produced RUTF.
- Children randomized to the second intervention arm (Arm 2) will receive a locally produced RUTF.
- Children randomized to the comparison group (Arm 3) will receive augmented Home-Prepared Foods.
The amount of food advised for each child in all the 3 study arms are calculated to provide 175cal/kg body weight per day. These foods will be given to children from the time of enrollment until recovery (but not beyond 16 weeks). Caregivers of all enrolled children will receive counseling on frequency of feeding, amounts to be fed, encouraging children to continue breastfeeding and good hygiene practices. Additional support through a volunteer from the community will be provided to mothers who give consent, to assist in feeding the child.
Management Phases: The management will be in two phases:
Treatment Phase: From enrolment until recovery or 16 weeks (whichever is earlier), enrolled children will be provided the foods according to the study group they are randomized to, and counselled on their use.
Sustenance Phase: After completion of the treatment phase, children in all arms will be referred to the closest Anganwadi centre from where he/she will access supplementary foods given to children as a part of the ICDS strategy. The sustenance phase will last for 16 weeks after end of treatment phase.
Outcomes: A trained and standardized team of field workers will conduct weekly anthropometric measurements and also record morbidity, hospitalizations and deaths from enrolment, weekly till recovery or 16 weeks whichever is earlier. In addition, mortality and hospitalization data will be collected at 16 weeks post treatment phase.
The primary outcome will be recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema).
Secondary outcomes will include:
- To compare the weight gain (in grams/kg body weight/day) from enrolment till recovery, or till 16 weeks in those who do not attain recovery, at 16 weeks after recovery.
- To compare the time required to reach recovery (in weeks).
- To determine the incidence and prevalence of diarrhea, ARI and fever during the treatment phase
- To compare the mortality and hospitalizations during the treatment phase, 16 weeks after recovery
- To compare the perceptions of families, health care providers and ICDS functionaries regarding feasibility of use of the feeding regimens in a sub sample from enrolment tom completion of treatment phase
- To ascertain factors which affect recovery, at 16 weeks post enrolment in those who do not recover.
- To compare the perceptions of families regarding Anganwadi centre experience at the end of sustenance phase.
- To compare the proportion of children with weight for height greater than or equal to -2 SD and absence of oedema feet at 16 weeks after recovery (or 32 weeks after enrolment for those who do not recover)
- To document the costs of implementing the feeding regimens till end of treatment phase.
This will include:
- Estimation of costs of human resource and other inputs
- Estimation of household costs
- Costs per week per child estimated based on total costs and covered population
The project has been approved by the National Research Alliance for SAM constituted by the Department of Health and Family Welfare, Department of Health Research and Department of Biotechnology. It will be coordinated by Centre for Health Research and Development-Society for Applied Studies. WHO will provide technical support and monitoring for the study implementation as a response to a request from the Alliance. Oversight to the study will be provided by a Technical Advisory group constituted by the Alliance and a Data Safety Monitoring Board. Clearances have been sought from the state governments of Delhi, Rajasthan and Tamil Nadu.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| RUTF-Centrally produced | Experimental | Other: Ready to Use Therapeutic Food-Centrally producedReady to Use Therapeutic Food-Centrally produced by an Indian company |
| RUTF-Locally produced | Experimental | Other: Ready to Use Therapeutic Food-Locally producedReady to Use Therapeutic Food-Locally produced by the study team at each study site |
| High energy and micronutrient rich foods | Active comparator | Other: High energy and micronutrient rich foodsHigh energy and micronutrient rich foods prepared by caregivers at home using ingredients provided to them |
Who may qualify
- Ages
- 6 to 59 months
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- Age 6 to 59 months
- SAM, defined as Weight for height less than -3 SD of WHO standard or oedema of both feet or both.
Key exclusion criteria (3 listed)
- Complicated SAM defined as child with SAM having signs of severe illness requiring hospitalization
- Known allergy to animal milk or peanuts
- Likely to leave the study area permanently in the next 16 weeks
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ready to Use Therapeutic Food-Centrally producedReady to Use Therapeutic Food-Centrally produced by an Indian company. | Other | RUTF-Centrally produced |
| Ready to Use Therapeutic Food-Locally producedReady to Use Therapeutic Food prepared by the study team | Other | RUTF-Locally produced |
| High energy and micronutrient rich foodsHigh energy and micronutrient rich foods prepared by caregivers at home using ingredients provided to them | Other | High energy and micronutrient rich foods |
Primary outcome
Recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema of both feet)
Time frame: Weekly till recovery or 16 weeks after enrollment, whichever is earlier
9 secondary outcomes
Mortality and hospitalizations
Time frame: Weekly till 16 weeks or recovery and at end of sustenance phase
Rate of weight gain (grams/kg body wt/day)
Time frame: From enrollment till recovery or 16 weeks whichever is earlier
Time required to reach recovery
Time frame: From enrollment till recovery or 16 weeks whichever is earlier
Íncidence and prevalence of diarrhea, ARI and fever during treatment phase
Time frame: From enrollment till recovery or 16 weeks whichever is earlier
Proportion of children with weight for height greater than or equal to -2 SD and absence of oedema of feet
Time frame: At the end of sustenance phase
Cost of three feeding regimens
Time frame: Enrollment to end of treatment phase
Feedback from families, health care providers and ICDS functionaries about the feeding regimens regarding perceptions and feasibility of use
Time frame: Enrollment to end study
Factors which affect recovery
Time frame: At 16 weeks post enrolment in those that have not recovered
Perception of families regarding anganwadi centre experiences at the end of sustenance phase
Time frame: from end of treatment phase to end of sustanence phase
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2015.
- Derived from this study: PubMed 29527358Garg CC, Mazumder S, Taneja S, Shekhar M, Mohan SB, Bose A, Iyengar SD, Bahl R, Martines J, Bhandari N. Costing of three feeding regimens for home-based management of children with uncomplicated severe acute malnutrition from a randomised trial in India. BMJ Glob Health. 2018 Mar 6;3(2):e000702. doi: 10.1136/bmjgh-2017-000702. eCollection 2018.
- Derived from this study: PubMed 28588982Bhandari N, Mohan SB, Bose A, Iyengar SD, Taneja S, Mazumder S, Pricilla RA, Iyengar K, Sachdev HS, Mohan VR, Suhalka V, Yoshida S, Martines J, Bahl R. Efficacy of three feeding regimens for home-based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Glob Health. 2016 Dec 30;1(4):e000144. doi: 10.1136/bmjgh-2016-000144. eCollection 2016.
Related trials for Uncomplicated Severe Acute Malnutrition
Not yet recruiting
The Relapse to Acute Malnutrition Prevention (RAMP) Trial
Acute Malnutrition in Childhood, Acute Malnutrition, Severe
RecruitingPhase 4
Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition
Malnutrition, Child, Severe Acute Malnutrition
Not yet recruiting
Microbiota Directed Food for Children With Severe Acute Malnutrition
Severe Acute Malnutrition
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nita Bhandari, MD, PhD principal investigator
Centre for Health Research and Development, Society for Applied Studies
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced and High energy and micronutrient rich foods in people with Uncomplicated Severe Acute Malnutrition, run by Society for Applied Studies at 3 sites in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema of both feet) (time frame: Weekly till recovery or 16 weeks after enrollment, whichever is earlier). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01705769, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2015.